Studies have shown that active fund managers routinely underperform the S&P500 index*​

60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP)

SXTP Stock Predictions and Ratings

WSX Rating:
STRONG BUY
WSX Forecast (1yr):
43.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
27.60%

SXTP Stock Analysis

SXTP PE Ratio:

SXTP PEG Ratio: Not Available

SXTP Forward EPS Growth (12 month): 0.00%

SXTP PS Ratio: 2.9

SXTP PSG Ratio: 0.1

SXTP Forward Revenue Growth (12 month): 47.40%

SXTP Articles

No data was found